GLMD
Galmed Pharmaceu (GLMD)
NASDAQ
$0.70+$0.005 (+0.71%)
Price as of Jun 03, 2026 6:25 PM EDT
  • $8.4M
    Market Cap
  • -53.30%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-4.9M
+63.61%
-3.0M
-16.53%
-3.6M
-72.54%
-13.0M
-52.26%
Depreciation and Amortization Expense
N/A
N/A
83,000
+167.74%
31,000
-11.43%
35,000
-16.67%
Total Operating Expenses
8.5M
+35.55%
6.3M
-16.20%
7.5M
-57.55%
17.7M
-46.32%
Operating Profit
7.5M
0.00%
7.5M
+208.75%
-6.9M
-61.31%
-17.9M
-44.97%
Interest Income
-914,000
+81.71%
-503,000
+34.13%
-375,000
+26.26%
-297,000
-171.74%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
-914,000
+81.71%
-503,000
+34.13%
-375,000
+26.26%
-297,000
-171.74%
Total Nonoperating Income and Expense
741,000
+43.60%
516,000
-11.03%
580,000
+369.77%
-215,000
-151.93%
Income before Taxes
7.5M
0.00%
7.5M
+208.75%
-6.9M
-61.31%
-17.9M
-44.97%
Income Taxes
0
N/A
N/A
N/A
16,000
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
1.1M
N/A
N/A
N/A
N/A
N/A
Net Income
6.9M
-13.75%
8.0M
+215.74%
-6.9M
-61.31%
-17.9M
-44.97%
Net Income from Continuing Operations Applicable to Common
7.5M
0.00%
7.5M
+208.75%
-6.9M
-61.31%
-17.9M
-44.97%
Basic EPS and Net Income
2.39
-70.42%
8.08
+223.20%
2.50
+252.11%
0.71
-46.21%
Diluted EPS and Net Income
2.39
-70.42%
8.08
+223.20%
2.50
+252.11%
0.71
-46.21%
Basic Weighted Average Shares
4.3M
+363.17%
930,822
-66.39%
2.8M
-88.98%
25.1M
+2.22%
Diluted Weighted Average Shares
4.3M
+363.17%
930,822
-66.39%
2.8M
-88.98%
25.1M
+2.22%
Balance Sheet
Cash and Cash Equivalents
4.0M
-14.34%
4.7M
+62.60%
2.9M
+41.91%
2.0M
-30.10%
Short-Term Investments
7.0M
-2.20%
7.2M
-4.58%
7.5M
-36.04%
11.8M
-63.14%
Cash and Cash Equivalents and Short-Term Investments
11.0M
-6.97%
11.8M
+13.92%
10.4M
-24.64%
13.8M
-60.40%
Total Current Assets
18.6M
+15.52%
16.1M
+21.79%
13.2M
-10.09%
14.7M
-59.16%
Accumulated Depreciation
N/A
N/A
1.1M
+8.24%
1.0M
+3.14%
988,000
+3.24%
Property and Plant and Equipment and Net
N/A
N/A
737,000
+787.95%
83,000
-27.19%
114,000
-21.38%
Total Long-Term Assets
N/A
N/A
2.4M
-29.91%
3.4M
+84.54%
1.8M
+233.39%
Total Assets
18.6M
+0.69%
18.5M
+11.25%
16.6M
+0.41%
16.6M
-54.76%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.8M
+30.92%
2.2M
-20.98%
2.8M
-11.12%
3.1M
-47.37%
Total Long-Term Debt
N/A
N/A
257,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
1.7M
+165.13%
628,000
+1,327.27%
44,000
-80.79%
Total Liabilities
2.8M
+30.92%
2.2M
-20.98%
2.8M
-12.36%
3.1M
-48.62%
Retained Earnings
-210.8M
+5.14%
-200.5M
+3.90%
-193.0M
+3.72%
-186.0M
+10.62%
Total Stockholders Equity
15.8M
-3.34%
16.3M
+17.64%
13.9M
+3.40%
13.4M
-55.99%
Total Shares Outstanding
6.6M
+295.31%
1.7M
-67.00%
5.0M
-79.98%
25.2M
+0.46%
Cash Flow
Cash from Operating Activities
-6.3M
+7.40%
-5.9M
-4.19%
-6.1M
-66.83%
-18.5M
-43.75%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
4,000
-63.64%
Cash from Investing Activities
-3.4M
+203.78%
-1.1M
-238.87%
800,000
-95.44%
17.6M
+53.23%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
9.0M
+2.73%
8.8M
+42.05%
6.2M
+8,735.71%
70,000
-99.60%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
37.17%
-18.39%
45.55%
+209.35%
-41.65%
-38.03%
-67.21%
-7.90%
Return on Equity
42.98%
-18.86%
52.97%
+204.61%
-50.63%
-37.76%
-81.36%
-6.47%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
6.55
-11.76%
7.42
+54.13%
4.81
+1.16%
4.76
-22.40%
Cash Ratio
1.40
-34.57%
2.14
+105.77%
1.04
+59.67%
0.65
+32.82%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow